Lung Cancer

Metformin Fails to Show Benefit in Non-Small Cell Lung Cancer Trials

By

Jon Kelvey

Publish Date August 12, 2021

Metformin did not improve progression-free or overall survival in either study.

Blood-Based Test May Establish a “New Paradigm” for Cancer Screening

By

Leah Lawrence

Publish Date August 5, 2021

The test can accurately detect cancer and predict where it is located, according to researchers.

Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer

By

Jon Kelvey

Publish Date July 30, 2021

The study showed differences by cancer type and race/ethnicity.

Lung Cancer Treatment May Impact Daily Function in Older Adults

Older adults with lung cancer may experience declines in life-space mobility during treatment, according to a study published.

Increased Respiratory Tract Cancers Linked to Low Sociodemographic Index

An analysis of the 2019 Global Burden of Disease Study offers insight into rates and risk factors for respiratory tract cancers globally, regionally, and nationally.

Downstream Invasive Procedures Occur for 7.4% After Lung Cancer Screen

The rates of invasive procedures after LDCT lung cancer screening are considerable and are associated with modest out-of-pocket costs.

Lurbinectedin Plus Doxorubicin Improves PFS, Not OS, in Small-Cell Lung Cancer

The 12-month progression-free survival rate was superior in the lurbinectedin arm.

Revised Guidelines Perpetuate Disparities in Lung Cancer Screening

Racial/ethnic disparities in lung cancer screening persist, even in revised eligibility guidelines from the USPSTF.